Related Experiment Videos
[Hyperthyroidism caused by a hormone-producing follicular thyroid cancer]
1Abteilung Innere Medizin I der Medizinischen Klinik, Universität-Heidelberg.
Klinische Wochenschrift
|March 1, 1989
Summary
Metastatic follicular thyroid carcinoma can rarely cause hyperthyroidism by secreting thyroid hormones. These metastases can also increase radioiodine uptake, even before thyroidectomy.
Area of Science:
- Endocrinology
- Oncology
- Nuclear Medicine
Background:
- Well-differentiated thyroid carcinomas typically exhibit reduced thyroid hormone production compared to normal thyroid tissue.
- Hyperthyroidism is an uncommon complication of follicular thyroid carcinoma, occurring very rarely in metastatic disease.
Observation:
- A patient with follicular thyroid carcinoma presented with increased radioiodine (123I) uptake in both the primary tumor and a lung metastasis prior to thyroidectomy.
- Iodine uptake in the contralateral, normal thyroid lobe was suppressed, indicating autonomous function of the metastatic lesion.
Findings:
- Metastatic follicular thyroid carcinoma lesions can achieve functional hormone secretion comparable to normal thyroid tissue.
- These metastases demonstrate enhanced radioiodine uptake, exceeding that of normal thyroid parenchyma.
Implications:
- This case highlights the potential for thyroid cancer metastases to cause clinical hyperthyroidism.
- Understanding the functional capacity of metastases is crucial for accurate diagnosis and treatment planning, including radioiodine therapy.